Poplitealvenous aneurysms (PVA) are associated with deep venous thrombosis and recurrentpulmonary thromboembolism (PE). We report three cases of PVA. In all three patients the fi rst sign of PVA was acute PE; in one case, the PE was recurrent. Computed tomography and duplex ultrasonography revealed not only PE but also popliteal venous dilatation with thrombus. Surgical reconstruction was performed in each case after treatment for PE. No postoperative complications occurred, including recurrent PE. Surgical repair of PVA is safe and is a recommended treatment.
Keywords: popliteal venous aneurysm, pulmonary thromboembolism, surgical repair inferior vena cava (IVC) fi lter (GüntherTulip; Cook Medical, Bloomington, Indiana, USA) was inserted. One day later, the patient became hypotensive and lost consciousness. Thrombosis of the pulmonary artery and popliteal vein were unchangedon repeat CT. The patient was intubated and was treated in intensive care for 27 days. Once her general condition stabilized, we performed surgical treatment for PVA. Lateral venorrhaphy was not possible because of inadequate healthy venous tissue. Aneurysmectomy and patch plasty with the saphenous vein were performed (Fig. 1) .
Case 2
A 77-year-old woman presented with palpitations and a history of PE 2 years earlier. The patient's IVC fi lter had been removed, and she had discontinued oral anticoagulation therapy on her own. CT showed PE and a dilated right popliteal vein. Venous ultrasonography demonstrated a multilocularsaccular PVA that had grown over the preceding 2 years. We initiated anticoagulation therapy after IVC fi lter placement. The patient underwent aneurysm resection with interposed polytetrafl uoroethyleneprosthesis (PTFE) 17 days later (Fig. 2) .
Case 3
A 76-year-old woman presented to another hospital with acute shortness of breath. She was admitted and treated there for heart failure. Two weeks later, the patient was transferred to our hospital because of hypoxia and hypotension. CT showed PE and deep vein thrombosis. Ultrasonography revealed right PVA and thrombus.
Introduction
Venous aneurysms are uncommon, unlike varicose veins caused by valvular dysfunction. Popliteal venous aneurysm (PVA) is potentially life threatening, because it can result in pulmonary thromboembolism (PE). Because the reported risk of recurrent PE is high in patients with PVA, even among those receiving anticoagulation treatment, surgical intervention is recommended. 1) We report three cases of PVA treated with surgical reconstruction using different procedures.
Case 1
A 65-year-old woman presented with exertional dyspnea. Computed tomography (CT) revealed PE. Venous ultrasonography revealed a thrombosed multilocularsaccular PVA. There was no history of previous venous thrombosis. Anticoagulation therapy was started, and a temporary duplex scanning demonstrated deep venous system patency without any symptoms in all cases.
Discussion
PVA is rare. There have been 212 reported cases since the fi rst report by May and Nisselin 1968. 2, 3) In 1976, Dahl et al. described the fi rst case of recurrent PE resulting from PVA. 4) According to a current review, 24-51% of patients with PVA present with PE. In 55-76% of patients, PVA is associated with chronic venous disease, including superficial vein insuffi ciency, leg swelling, and venous ulceration. 1, 5) Rupture is a rare complication of PVA. 5) The etiology of PVA remains unknown, and no association with arterial aneurysm has been reported.
Various modalities are available to diagnose PVA, including phlebography, duplex ultrasonography, and computed tomography (CT). Venous duplex scanning is the best noninvasive diagnostic method to assess lower limb deep vein aneurysm, and to determine aneurysm size and morphology.
Most PVAs are saccular (72-88% of cases); the remainder are fusiform. 1, 6) Thrombus formation within the aneurysmal sac is found in approximately two-thirds of PVA patents. Although large or saccular aneurysms are more prone to thromboembolic complications, there are no size criteria to defi nitely label a venous fusiform dilatation of an aneurysm. Maleti et al. defi ned aneurysm as a venous fusiform dilatation >20 mm, at least three times the size of the normal popliteal vein. 7) Anticoagulation therapy alone may not prevent PE in patients with symptomatic PVA, and its sole use as treatment is associated with a high incidence of recurrence. 1, 3, 5, 6, 8) Given the potential for serious thromboembolic complications, surgical repair is indicated in all symptomatic patients. However, management of asymptomatic PVA remains a controversial issue. Two case series have described the course of asymptomatic patients with fusiform and saccular PVAs. 1) Although untreated, none of these patients experienced thromboembolic events. However, the size of the aneurysms was quite small and follow-up was short. Maldonado-Fernandez et al. reported fi ve deaths resulting from PE in patients receiving medical treatment for PVA. 3) Therefore, regardless of symptoms, most investigators consider surgery is the best treatment for PVA, indicated for all saccular aneurysms and for fusiform aneurysms >20 mm.
PVA does not present with specifi c, defi nite signs, or symptoms. Only 20% of reported cases had a palpable mass in the popliteal fossa, 3) making PVA diffi cult to diagnose in asymptomatic patients. In these cases, there is no need to pursue duplex ultrasonography as a screening subsequent surgery. In case 3, the thrombus disappeared within 10 days, and the patient did not wish to pursue surgery immediately. Hence, the IVC fi lter was removed, and surgery was performed approximately 5 months later. Most patients receive oral anticoagulation for 3 to 6 months. 1, 3, 9) However, we recommended permanent use of compression stockings and oral anticoagulationtherapy with Vitamin K antagonist to our patients, because all three had severe PE.
Conclusion
PVA is uncommon but can cause fatal or recurrent PE. Therefore, PVA should be kept in mind in cases of thromboembolism. The most effective treatment to prevent PE in patients with PVA is surgical repair rather than anticoagulation therapy.
test. However, all PE patients should undergo CT phlebography and duplex ultrasonography with PVA in mind. As shown in our three cases, PE with PVA can be severe or recurrent, and a cure is possible with surgery. Maldonado-Fernandez et al. reviewed the records of 102 patients who underwent surgical treatment for PVA. 3) No mortality, major complications, or repeat thromboembolic events occurred in these patients. However, there were several minor complications. Early complications, including hematoma, transient nerve injury, infection, and thrombosis of the surgical repair, occurred in 20% of patients. Late complications developed in 4%, including thrombosis from the procedure (one case) and relapse of the venous aneurysm (three cases).
Various operative procedures have been used for venous reconstruction and the incidence of complications varies greatly according to operation method. Aneurysm resection with preservation of venous continuity is recommended. In particular, tangential aneurysmectomy with lateral venorrhaphyis the preferred technique, because of its lower complication rate compared with other procedures. In contrast, resection of aneurysms with end-toend anastomosis is not considered effective because it carries a high risk of early thrombosis.
Only one of our cases was treated with tangential aneurysmectomy with lateral venorrhaphy. Direct suturing was not possible in the other cases because of inadequate remaining healthy venous area or large native venous diameter. In case 2, the native venous diameter after PVA resection was 10 mm, making it unsuitable for interposition with a saphenous veingraft. Generally, reconstruction using an autologous graft is the preferred method. However, thrombosis has been reported in a patient who received an interposition graft using the internal jugular vein. 6) Although we considered using a spliced vein graft, we opted for a ringed PTFE graft, which has high antithrombogenicity, is not diffi cult to use, and is not timeconsuming. IVC fi lter placement is not recommended in current American College of Chest Physicians or European Society of Cardiology guidelines on PE treatment. Patient 1 deteriorated substantially despite IVC fi lter implantation. We could not determine whether new embolization had occured through the fi lter or pulmonary embolism had progressed. However, preventive IVC fi lter placement is thought to reduce the risk of embolism during surgical repair of deep vein aneurysm or when thrombosis recurs in the surgical area. All of our patients had acute PE with PVA on admission. The IVC fi lter was placed to allow
